[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @AceStocks88 Tanner H. Tanner H. posts on X about $lyra, market cap, os, $prax the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1404048603706970114/interactions)  - X Week XXXXX +152% - X Month XXXXX +1,140% - X Months XXXXXX +235% - X Year XXXXXX +52% ### Mentions: X [#](/creator/twitter::1404048603706970114/posts_active)  - X Week XX +111% - X Month XX +500% - X Months XX +209% - X Year XX +150% ### Followers: XXX [#](/creator/twitter::1404048603706970114/followers)  - X Week XXX +2.60% - X Month XXX +5.90% - X Months XXX +21% - X Year XXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1404048603706970114/influencer_rank)  ### Social Influence [#](/creator/twitter::1404048603706970114/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXXX% [finance](/list/finance) XXXX% **Social topic influence** [$lyra](/topic/$lyra) #5, [market cap](/topic/market-cap) #1539, [os](/topic/os) 8.7%, [$prax](/topic/$prax) 6.52%, [$mira](/topic/$mira) 6.52%, [$vivk](/topic/$vivk) 6.52%, [$sprb](/topic/$sprb) 6.52%, [$ttrx](/topic/$ttrx) 6.52%, [runner](/topic/runner) 2.17%, [cuts](/topic/cuts) XXXX% **Top accounts mentioned or mentioned by** [@stockplaymaker1](/creator/undefined) [@uavcorp](/creator/undefined) [@maceosremy](/creator/undefined) [@curiosg1985](/creator/undefined) [@northshoretrade](/creator/undefined) [@moonmarket](/creator/undefined) [@mmatters22596](/creator/undefined) [@hedgenomix](/creator/undefined) [@johnzidar](/creator/undefined) [@topstockalerts1](/creator/undefined) [@jacobsjones92](/creator/undefined) [@kennyfharris](/creator/undefined) [@ordinaryinvestr](/creator/undefined) [@jacksurvived](/creator/undefined) [@learningdatruth](/creator/undefined) [@spartatrades](/creator/undefined) [@cofffree](/creator/undefined) [@sarwanjohn](/creator/undefined) [@dehixtrades](/creator/undefined) [@ttstocks](/creator/undefined) **Top assets mentioned** [LYRA (LYRA)](/topic/$lyra) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Chains of War (MIRA)](/topic/$mira) ### Top Social Posts [#](/creator/twitter::1404048603706970114/posts) --- Top posts by engagements in the last XX hours "@stockplaymaker1 $LYRA small float bio worth watching w/ Phase X assets and sub 15M market cap. 1.64M OS; 1.12M float" [X Link](https://x.com/AceStocks88/status/1975980988477079954) [@AceStocks88](/creator/x/AceStocks88) 2025-10-08T17:45Z XXX followers, XXX engagements "@coff_free @SarwanJohn I like $LYRA as well. It has an active Phase X asset; cash runway into 2026 + just 1.6ish Million OS. Float just over 1M" [X Link](https://x.com/AceStocks88/status/1976667513481236723) [@AceStocks88](/creator/x/AceStocks88) 2025-10-10T15:13Z XXX followers, XXX engagements "@stockplaymaker1 $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M" [X Link](https://x.com/AceStocks88/status/1976868786310373850) [@AceStocks88](/creator/x/AceStocks88) 2025-10-11T04:33Z XXX followers, XXX engagements "@MMatters22596 $LYRA" [X Link](https://x.com/AceStocks88/status/1977219964554678458) [@AceStocks88](/creator/x/AceStocks88) 2025-10-12T03:49Z XXX followers, XXX engagements "@MMatters22596 Agree this is a good time for biotech with rate cuts (hopefully) & better access to financing. More consolidation and M & A activity in space too. Like late stage + commercial in particular. One example is $LYRA w/ Ph3 asset and a successful trial already. Many though" [X Link](https://x.com/AceStocks88/status/1977509758266392783) [@AceStocks88](/creator/x/AceStocks88) 2025-10-12T23:00Z XXX followers, XXX engagements "$LYRA under the radar biotech IMO. Market Cap of 12.4M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. $PRAX $MIRA $VIVK $SPRB $TTRX" [X Link](https://x.com/AceStocks88/status/1979036375199453204) [@AceStocks88](/creator/x/AceStocks88) 2025-10-17T04:06Z XXX followers, XX engagements "$LYRA reminds me of $SNSE. Market Cap of 11.8M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. Just need updates. $PRAX $MIRA $VIVK $SPRB $TTRX" [X Link](https://x.com/AceStocks88/status/1979168996499824827) [@AceStocks88](/creator/x/AceStocks88) 2025-10-17T12:53Z XXX followers, XX engagements "@TT_stocks_ I like $LYRA for a watch anyway. Has an active Phase X asset and previously ran from X to XX. FDA wants one more trial but still relatively cheap here. 1.6M OS" [X Link](https://x.com/AceStocks88/status/1978553456521589155) [@AceStocks88](/creator/x/AceStocks88) 2025-10-15T20:07Z XXX followers, XXX engagements "@SuperDuperInvst If $LYRA gets partnership news for financing Ph3 trial or other big news it might. 1.6M OS Biotech" [X Link](https://x.com/AceStocks88/status/1978554108127711611) [@AceStocks88](/creator/x/AceStocks88) 2025-10-15T20:10Z XXX followers, XXX engagements "@stockplaymaker1 $LYRA under the radar biotech IMO. Market Cap of 12.4M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. $PRAX $MIRA $VIVK $SPRB $TTRX" [X Link](https://x.com/AceStocks88/status/1978867561254080637) [@AceStocks88](/creator/x/AceStocks88) 2025-10-16T16:56Z XXX followers, XXX engagements "@Hedgenomix @stockplaymaker1 😂. I dont think there are too many retail owners but its a sleeper IMO. With low OS I think a market cap of 11M is diabolical for a co. with an asset in Phase X for something as common as sinusitis. They have to do one more trial due to a design issue but I like $LYRA here" [X Link](https://x.com/AceStocks88/status/1979318043353456810) [@AceStocks88](/creator/x/AceStocks88) 2025-10-17T22:46Z XXX followers, XX engagements "@UAV_Corp Wed also like to know exactly how close we are to obtaining the 50M term sheet closure & end of dilution / debt repayment. Is the weight balance analysis a condition precedent for that I sincerely hope there will be no further AS raises and no reverse split" [X Link](https://x.com/AceStocks88/status/1979531933911805995) [@AceStocks88](/creator/x/AceStocks88) 2025-10-18T12:56Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AceStocks88 Tanner H.
Tanner H. posts on X about $lyra, market cap, os, $prax the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +152%
- X Month XXXXX +1,140%
- X Months XXXXXX +235%
- X Year XXXXXX +52%
Mentions: X #
- X Week XX +111%
- X Month XX +500%
- X Months XX +209%
- X Year XX +150%
Followers: XXX #
- X Week XXX +2.60%
- X Month XXX +5.90%
- X Months XXX +21%
- X Year XXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence cryptocurrencies XXXXX% finance XXXX%
Social topic influence $lyra #5, market cap #1539, os 8.7%, $prax 6.52%, $mira 6.52%, $vivk 6.52%, $sprb 6.52%, $ttrx 6.52%, runner 2.17%, cuts XXXX%
Top accounts mentioned or mentioned by @stockplaymaker1 @uavcorp @maceosremy @curiosg1985 @northshoretrade @moonmarket @mmatters22596 @hedgenomix @johnzidar @topstockalerts1 @jacobsjones92 @kennyfharris @ordinaryinvestr @jacksurvived @learningdatruth @spartatrades @cofffree @sarwanjohn @dehixtrades @ttstocks
Top assets mentioned LYRA (LYRA) Praxis Precision Medicines, Inc. Common Stock (PRAX) Chains of War (MIRA)
Top Social Posts #
Top posts by engagements in the last XX hours
"@stockplaymaker1 $LYRA small float bio worth watching w/ Phase X assets and sub 15M market cap. 1.64M OS; 1.12M float"
X Link @AceStocks88 2025-10-08T17:45Z XXX followers, XXX engagements
"@coff_free @SarwanJohn I like $LYRA as well. It has an active Phase X asset; cash runway into 2026 + just 1.6ish Million OS. Float just over 1M"
X Link @AceStocks88 2025-10-10T15:13Z XXX followers, XXX engagements
"@stockplaymaker1 $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M"
X Link @AceStocks88 2025-10-11T04:33Z XXX followers, XXX engagements
"@MMatters22596 $LYRA"
X Link @AceStocks88 2025-10-12T03:49Z XXX followers, XXX engagements
"@MMatters22596 Agree this is a good time for biotech with rate cuts (hopefully) & better access to financing. More consolidation and M & A activity in space too. Like late stage + commercial in particular. One example is $LYRA w/ Ph3 asset and a successful trial already. Many though"
X Link @AceStocks88 2025-10-12T23:00Z XXX followers, XXX engagements
"$LYRA under the radar biotech IMO. Market Cap of 12.4M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. $PRAX $MIRA $VIVK $SPRB $TTRX"
X Link @AceStocks88 2025-10-17T04:06Z XXX followers, XX engagements
"$LYRA reminds me of $SNSE. Market Cap of 11.8M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. Just need updates. $PRAX $MIRA $VIVK $SPRB $TTRX"
X Link @AceStocks88 2025-10-17T12:53Z XXX followers, XX engagements
"@TT_stocks_ I like $LYRA for a watch anyway. Has an active Phase X asset and previously ran from X to XX. FDA wants one more trial but still relatively cheap here. 1.6M OS"
X Link @AceStocks88 2025-10-15T20:07Z XXX followers, XXX engagements
"@SuperDuperInvst If $LYRA gets partnership news for financing Ph3 trial or other big news it might. 1.6M OS Biotech"
X Link @AceStocks88 2025-10-15T20:10Z XXX followers, XXX engagements
"@stockplaymaker1 $LYRA under the radar biotech IMO. Market Cap of 12.4M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. $PRAX $MIRA $VIVK $SPRB $TTRX"
X Link @AceStocks88 2025-10-16T16:56Z XXX followers, XXX engagements
"@Hedgenomix @stockplaymaker1 😂. I dont think there are too many retail owners but its a sleeper IMO. With low OS I think a market cap of 11M is diabolical for a co. with an asset in Phase X for something as common as sinusitis. They have to do one more trial due to a design issue but I like $LYRA here"
X Link @AceStocks88 2025-10-17T22:46Z XXX followers, XX engagements
"@UAV_Corp Wed also like to know exactly how close we are to obtaining the 50M term sheet closure & end of dilution / debt repayment. Is the weight balance analysis a condition precedent for that I sincerely hope there will be no further AS raises and no reverse split"
X Link @AceStocks88 2025-10-18T12:56Z XXX followers, XXX engagements